A new Northwestern Medicine study published in the Proceedings of the National Academy of Sciences has explored the impacts ...

A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.

Neo7Bioscience Announces Precision Signal Interception for Pancreatic Cancer Treatment Beyond Conventional RAS Pathway Suppression ...

Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally. To overcome this ...

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 ...

For the second successive year, an Oxford trailblazer has won the MacRobert Award from The Royal Academy of Engineering.

Competitive CDMRP award funds preclinical programs against two cryptic cell-surface targets discovered directly in patient tumors using the company's AI-powered RyboCypher™ platform and CypherAtlas™ ...

Primary bone tumors, such as osteosarcoma, have seen stagnant survival rates over the past four decades. Surgical removal of the tumor is critical, but local recurrence may occur when tumours are ...

Permafrost usually hits the news as a hazard; a planetary risk. When this ice-rich ground thaws, it damages roads and building foundations. It drains lakes and tips trees into drunken forests. It ...

Prime Medicine, Inc. wins arbitration vs. Beam Therapeutics Inc., advancing PM647 for AATD. Read more on PRME and BEAM stocks ...